Reframing HIV care: Putting people at the centre of antiretroviral delivery

Tropical Medicine and International Health

Volumn 20, Issue 4, 2015, Pages 430-447

  Duncombe, Chris ^a   Rosenblum, Scott ^a   Hellmann, Nicholas ^b   Holmes, Charles ^c   Wilkinson, Lynne ^d   Biot, Marc ^d   Bygrave, Helen ^d   Hoos, David ^e   Garnett, Geoff ^a  

^a BILL AND MELINDA GATES FOUNDATION   (United States)

^b ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION   (United States)

^c CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^d MÉDECINS SANS FRONTIÈRES   (Belgium)

^e Columbia University ^*  (United States)

Author keywords

AIDS; Antiretroviral treatment, highly active; Cascade; Decentralisation; HIV; Optimised care; Patient centred care; Task shifting

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DECENTRALIZATION; HEALTH SERVICES; HUMAN IMMUNODEFICIENCY VIRUS; INNOVATION; OPTIMIZATION;

ANTIVIRAL THERAPY; DECENTRALIZATION; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT CARE; PATIENT REFERRAL; PRIMARY MEDICAL CARE; REVIEW; HEALTH SERVICE; HIV INFECTIONS;

ANTI-HIV AGENTS; HEALTH SERVICES; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; PATIENT-CENTERED CARE;

EID: 84924231388     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12460     Document Type: Review

References (30)

1. Eaton JW, Menzies NA, Stover J et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health 2014: 2(1): e23-34. doi: 10.1016/S2214-109X(13)70172-4. Epub 2013 Dec 10.
2. Kates J & Wexler A & Kaiser Family Foundaiton. Financing the response to AIDS in low- and middle-income countries: International Assistance from Donor Governments in 2013. (Available from: https://kaiserfamilyfoundation.files.wordpress.com/2014/07/7347-10-financing-the-response-to-hiv-in-low-and-middle-income-countries.pdf).
3. El-Sadr WM, Holmes CB, Mugyenyi P et al. Scale-up of HIV treatment through PEPFAR: a historic public health achievement. J Acquir Immune Defic Syndr 2012: 60(Suppl 3): S96-S104.
4. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2013, 2013. (Available from: http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf).
5. Katz IT, Bassett IV, Wright AA. PEPFAR in transition-implications for HIV care in South Africa. N Engl J Med 2013: 369: 1385-1387.
6. Rosen S & Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 2011: 8.
7. Boyd MA, Cooper DA. Optimisation of HIV care and service delivery: doing more with less. Lancet 2012: 380: 1860-1866.
8. Barnabas RV, van Rooyen H, Tumwesigye E et al. Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prospective, observational intervention study. Lancet HIV 2014: 1: e68-e76.
9. McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review. Bull World Health Organ 2013: 91: 377-385E.
10. Elul B, Nuwagaba-Biribonwoha H, Basinga P et al. High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda. PLoS Med 2013: 8.
11. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health 2010: 15: 1-15.
12. Kredo T, Bateganya M, Pienaar ED et al. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2012. (Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007331.pub2/abstract).
13. Holmes C, Pillay Y, Mwango A et al. Health systems implications of the 2013 WHO consolidated antiretroviral guidelines and strategies for successful implementation. AIDS 2014: 28(Suppl 2): S231-S239.
14. Kredo T, Ford N, Adeniyi FB et al. Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd, 2013). (Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009987.pub2/abstract).
15. Fatti G, Grimwood A & Bock P. Better antiretroviral therapy outcomes at primary healthcare facilities: an evaluation of three tiers of ART services in four South African provinces. PLoS Med 2010: 5.
16. Decroo T, Panunzi I, das Dores C et al. Lessons learned during down referral of antiretroviral treatment in Tete, Mozambique. J Int AIDS Soc 2009: 12: 6.
17. Babigumira JB, Castelnuovo B, Lamorde M et al. Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda. BMC Health Serv Res 2009: 9: 192.
18. Bemelmans M, Baert S, Goemaere E. Community-supported models of care for people on HIV treatment in sub-Saharan Africa. Trop Med Int Health 2014: 19(8): 968-997. doi: 10.1111/tmi.12332.
19. Brennan A, Long L, Maskew M et al. Outcomes of stable HIV-positive patients down-referred from doctor-managed ART clinics to nurse-managed primary health clinics for monitoring and treatment. AIDS 2011: 25: 2027-2036.
20. Long L, Brennan A, Fox MP et al. Treatment outcomes and cost-effectiveness of shifting management of stable art patients to nurses in South Africa: an observational cohort. PLoS Med 2011: 8: e1001055.
21. Fairall L, Bachmann MO, Lombard C et al. Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial. Lancet 2012: 380: 889-898.
22. Kipp W, Konde-Lule J, Saunders D et al. Antiretroviral treatment for HIV in rural Uganda: two-year treatment outcomes of a prospective health centre/community-based and hospital-based cohort. PLoS Med 2012: 7.
23. Jaffar S, Amuron B, Foster S et al. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet 2009: 374: 2080-2089.
24. Selke HM, Kimaiyo S, Sidle JE et al. Task-shifting of antiretroviral delivery from health care workers to persons living with HIV/AIDS: clinical outcomes of a community-based program in Kenya. J Acquir Immune Defic Syndr 2010: 55: 483-490.
25. Decroo T, Koole O, Remartinez D et al. Four-year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique. Trop Med Int Health 2014: 19: 514-521.
26. Luque-Fernandez MA, Van Cutsem G, Goemaere E et al. Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in khayelitsha, Cape Town, South Africa. PLoS Med 2013: 8.
27. Amuron B, Levin J, Birunghi J et al. Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study. AIDS Res Ther 2011: 8: 39.
28. Zuber A, McCarthy CF, Verani AR et al. A survey of nurse-initiated and -managed antiretroviral therapy (NIMART) in practice, education, policy, and regulation in east, central, and Southern Africa. J Assoc Nurses AIDS Care 2014: 25: 520-531.
29. Babigumira JB, Castelnuovo B, Lamorde M et al. Cost effectiveness of a pharmacy-only refill program in a large urban HIV/AIDS clinic in Uganda. PLoS One 2011: 6: e18193.
30. Humphreys CP, Wright J, Walley J et al. Nurse led, primary care based antiretroviral treatment versus hospital care: a controlled prospective study in Swaziland. BMC Health Serv Res 2010: 10: 229.